Vinorelbine and Celecoxib in Treating Women With Relapsed or Metastatic Breast Cancer
Stopped early · Phase 1
Conditions studied: Breast Cancer
In brief
RATIONALE: Celecoxib may stop the growth of tumor cells by blocking the enzymes necessary for tumor cell growth. Drugs used in chemotherapy, such as vinorelbine, work in different ways to stop tumor cells from dividing so they stop growing or die. Combining vinorelbine with celecoxib may kill more tumor cells. PURPOSE: Phase I trial to determine the effectiveness of combining vinorelbine with celecoxib in treating women who have relapsed or metastatic breast cancer.
Key facts
- Study ID
- NCT00075673
- Run by
- Case Comprehensive Cancer Center
- People needed
- 6
- Starts
- 2003-11-01
- Expected to finish
- 2005-02-01
- Last updated by the study team
- 2020-07-27
Who can join
Age: 18 and older, up to 120. Sex: female. Healthy volunteers: not accepted.
Where it is running
- Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center — Cleveland, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.